Early Lymphoid Development and Microenvironmental Cues in B-cell Acute Lymphoblastic Leukemia

Archives of Medical Research

Volumn 43, Issue 2, 2012, Pages 89-101

  Purizaca, Jessica ^a,b   Meza, Isaura ^b   Pelayo, Rosana ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Acute lymphoblastic leukemia; Bone marrow microenvironment; Hematopoietic niche; Leukemic microenvironment; Lymphoid development

Indexed keywords

CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; IKAROS TRANSCRIPTION FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN EBF1; STAT5 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PAX5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; WNT3A PROTEIN; WNT5A PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; B LYMPHOCYTE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; LYMPHOPOIESIS; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE;

HUMANS; LEUKEMIA, B-CELL; TRANSCRIPTION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 84860608847     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.03.005     Document Type: Review

References (130)

1. Baba Y., Pelayo R., Kincade P.W. Relationships between hematopoietic stem cells and lymphocyte progenitors. Trends Immunol 2004, 25:645-649.
2. Seita J., Weissman I.L. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2010, 2:640-653.
3. Quesenberry P.J., Colvin G.A., Lambert J.F. The chiaroscuro stem cell: a unified stem cell theory. Blood 2002, 100:4266-4271.
4. Brown G., Hughes P.J., Michell R.H., et al. The sequential determination model of hematopoiesis. Trends Immunol 2007, 28:442-448.
5. Cederig R., Rolink A.G., Brown G. Models of haematopoiesis: seeing the wood for the trees. Nat Rev Immunol 2009, 9:293-300.
6. Quesenberry P.J., Colvin G.A., Abedi M., et al. The stem cell continuum. Ann NY Acad Sci 2005, 1044:228-235.
7. Pelayo R., Welner R.S., Perry S.S., et al. Lymphoid progenitors and primary routes to becoming cells of the immune system. Curr Opin Immunol 2005, 17:100-107.
8. Pelayo R., Welner R.S., Nagai Y., et al. Life before the pre-B cell receptor checkpoint: specification and commitment of primitive lymphoid progenitors in adult bone marrow. Semin Immunol 2006, 18:2-11.
9. Welner R.S., Pelayo R., Kincade P.W. Evolving views on the genealogy of B cells. Nat Rev Immunol 2008, 8:95-106.
10. + lymphoid progenitors. Blood 2007, 109:4825-4831.
11. Pelayo R., Hirose J., Huang J., et al. Derivation of two categories of plasmacytoid dendritic cells in murine bone marrow. Blood 2005, 105:4407-4415.
12. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
13. Welner R.S., Pelayo R., Nagai Y., et al. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 2008, 112:3753-3761.
14. Baldridge M.T., King K.Y., Goodell M.A. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol 2011, 32:57-65.
15. Blom B., Spits H. Development of human lymphoid cells. Annu Rev Immunol 2006, 24:287-320.
16. Notta F., Doulatov S., Laurenti E., et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
17. Doulatov S., Notta F., Eppert K., et al. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010, 11:585-593.
18. Rossi M.I., Yokota T., Medina K.L., et al. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood 2003, 101:576-584.
19. Hoebeke I., Smedt M., Stolz F., et al. T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34+CD38-CD7+ common lymphoid progenitors expressing lymphoid-specific genes. Leukemia 2007, 21:311-319.
20. Ichii M., Oritani K., Yokota T., et al. The density of CD10 corresponds to commitment and progression in the human B lymphoid lineage. PloS One 2010, 5:e12954.
21. + cells via mitogen-activated protein kinase-dependent and NF-kB-independent pathways. Int Immunol 2005, 17:1525-1531.
22. Pérez-Saldivar M.L., Fajardo-Gutiérrez A., Bernaldez-Ríos R., et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer 2011, 11:355-365.
23. Pérez-Vera P., Reyes-León A., Fuentes-Pananá E.M. Signalling proteins and transcription factors in normal and malignant early B cell development. Bone Marrow Res 2011, ID 502751.
24. Pelayo R, Dorantes-Acosta E, Vadillo E, et al. From HSC to B-lymphoid cells in normal and malignant hematopoiesis. In: Pelayo R, ed. Advances in Hematopoietic Stem Cell Research, ISBN: 979-953-307-661-3, InTech 2011, in press.
25. Mejía-Aranguré J.M., Pérez-Saldivar M.L., Pelayo-Camacho R., et al. Childhood acute leukemias in Hispanic population: differences by age peak and immunophenotype. Novel Aspects in Acute Lymphoblastic Leukemia 2011, 3-32. InTech Press, Croatia. 1st ed. S. Faderl (Ed.).
26. Lilljebjorn H., Rissler M., Lassen C., et al. Whole-exome sequencing of pediatric acute lymphoblastic leukemia. Leukemia 2011, 10.1038/leu.2011.333.
27. Zuna J., Madzo J., Krejci O., et al. ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia. Blood 2011, 117:368-369.
28. Hoelbl A., Schuster C., Kovacic B., et al. Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. EMBO Mol Med 2010, 2:98-110.
29. Espinoza-Hernández L., Cruz-Rico J., Benítez-Aranda H., et al. In vitro characterization of the hematopoietic system in pediatric patients with acute lymphoblastic leukemia. Leuk Res 2001, 25:295-303.
30. Cobaleda C., Gutiérrez-Cianca N., Pérez-Losada J., et al. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 2000, 95:1007-1013.
31. Cox C.V., Evely R.S., Oakhill A., et al. Characterization of acute lymphoblastic leukemia progenitor cells. Blood 2004, 104:2919-2925.
32. Cox C.V., Diamanti P., Evely R.S., et al. Expression of CD133 on leukemia-initiating cells in childhood ALL. Blood 2009, 113:3287-3295.
33. Castor A., Nilsson l, Astrand-Grundstrom I., et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 2005, 11:630-637.
34. Heidenreich O., Vormoor J. Malignant stem cells in childhood ALL: the debate continues!. Blood 2009, 113:4476-4477.
35. Le Viseur C., Hotfilder M., Bomken S., et al. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 2008, 14:47-58.
36. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
37. Notta F., Mullighan C.G., Wang J.C.Y., et al. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011, 469:362-367.
38. Chiu P.P.L., Jiang H., Dick J.E. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood 2010, 116:5268-5279.
39. Kamdje A.H.N., Krampera M. Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment?. Blood 2011, 118:6506-6514.
40. Mayani H. Composition and function of the hemopoietic microenvironment in human myeloid leukemia. Leukemia 1996, 10:1041-1047.
41. Nagasawa T., Omatsu Y., Sugiyama T. Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells. Trends Immunol 2011, 32:315-320.
42. Mercier F.E., Ragu C., Scadden D.T. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 2012, 12:49-60.
43. Takubo K., Goda N., Yamada W., et al. Regulation of the HIF1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010, 7:391-402.
44. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 2011, 208:421-428.
45. Renström J., Kröger M., Peschel C., et al. How the niche regulates hematopoietic stem cells. Chem Biol Interact 2010, 184:7-15.
46. Nemeth M.J., Bodine D.M. Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways. Cell Res 2007, 17:746-758.
47. Arai F., Yoshihara H., Hosokawa K., et al. Niche regulation of hematopoietic stem cells in the endosteum. Hematopoietic Stem Cells VII. Ann NY Acad Sci 2009, 1176:36-46.
48. Nakamura Y., Arai F., Iwasaki H., et al. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 2010, 116:1422-1432.
49. Wilson A., Laurenti E., Trumpp A. Balancing dormant and self-renewing hematopoietic stem cells. Curr Opin Genet Devel 2009, 19:461-468.
50. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
51. Kiel M.J., Radice G.L., Morrison S.J. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 2007, 1:204-217.
52. Kiel M.J., Acar M., Radice G.L., et al. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 2009, 4:170-179.
53. Nagasawa T. New niches for B cells. Nature Immunol 2008, 9:345-346.
54. Kiel M.J., Yilmaz O.H., Iwashita T., et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
55. Hooper A.T., Butler J.M., Nolan D.J., et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009, 4:263-274.
56. Kobayashi H., Butler J.M., O'Donell R., et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2010, 12:1046-1056.
57. Boyerinas B., Sipkins D.A. HSPCs in the balance: the vascular niche. Cell Stem Cell 2010, 7:645-646.
58. Wang L.D., Wagers A.J. Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol 2011, 12:643-655.
59. Doan P.L., Chute J.P. The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia 2012, 26:54-62.
60. Méndez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
61. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 8:290-301.
62. Bianco P. The stem cell next door: skeletal and hematopoietic stem cell niches in bone. Endocrinology 2011, 152. 000-000, doi:10.1210/en.2011-0217.
63. Barros A.P.D.N., Takiya C.M., Garzoni L.R., et al. Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model. PLoS One 2010, 5:e9093.
64. Leisten I., Kramann R., Ferreira M.S.V., et al. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials 2012, 33:1736-1747.
65. Mayani H., Guilbert L.J., Janowska-Wieczorek A. Biology of the hematopoietic microenvironment. Eur J Haematol 1992, 49:225-233.
66. Schajnovitz A., Itkin T., D'Uva G., et al. CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nat Immunol 2011, 12:391-398.
67. Omatsu Y., Sugiyama T., Kohara H., et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33:387-399.
68. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
69. Jarvis L.J., Maguire J.E., LeBien T.W. Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. Blood 1997, 90:1626-1635.
70. Tokoyoda K., Egawa T., Sugiyama T., et al. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
71. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006, 6:107-116.
72. Sapoznikov A., Pewzner-Jung Y., Kalchenko V., et al. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 2008, 9:388-395.
73. Labrie J.E., Borghesi L., Gerstein R.M. Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generation. Sem Immunol 2005, 17:347-355.
74. Pifer J., Stephan R.P., Lill-Elghanian D.A., et al. Role of stromal cells and their products in protecting young and aged B-lineage precursors from dexamethasone-induced apoptosis. Mech Ageing Dev 2003, 124:207-218.
75. Wu J.Y., Purton L.E., Rodda S.J., et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways. Proc Natl Acad Sci USA 2008, 105:16976-16981.
76. Kiuru M., Hidaka C., Hubner R.H., et al. Sonic hedgehog expands diaphyseal trabecular bone altering bone marrow niche and lymphocyte compartment. Mol Ther 2009, 17:1442-1452.
77. Malhotra S., Baba Y., Garrett K.P., et al. Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals. J Immunol 2008, 181:3955-3964.
78. Oliveira F.L., Brand C., Paula A.A., et al. Lack of Galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of S. mansoni infection. PLoS One 2011, 6:e19216.
79. Flores-Figueroa E., Gutierrez-Espíndola G., Montesinos J.J., et al. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 2002, 26:677-686.
80. Flores-Figueroa E., Arana-Trejo R.M., Gutierrez-Espindola G., et al. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 2005, 29:215-224.
81. Flores-Figueroa E., Montesinos J.J., Flores-Guzmán P., et al. Functional analysis of myelodysplastic syndrome-derived mesenchymal stem cells. Leuk Res 2008, 32:1407-1416.
82. Raaijmakers M.H., Mukherjee S., Guo S., et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010, 464:852-857.
83. Corre J., Mahtouk K., Attal M., et al. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia 2007, 21:1079-1088.
84. Mayani H., Guilbert L., Clark S.C., et al. Composition and functional integrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor. Exp Hematol 1992, 20:1077-1084.
85. Zhang H.M., Zhang L.S. Influence of human bone marrow mesenchymal stem cells on proliferation of chronic myeloid leukemia cells. Ai Zheng 2009, 28:29-32.
86. Yun J., Behan J., Heisterkamp N., et al. Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models. Cancer Prev Res 2010, 3:1259-1264.
87. Moschovi M., Trimis G., Vounatsou M., et al. Serial plasma concentrations of adiponectin, leptin, and resistin during therapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2010, 32:e8-e13.
88. + acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 2009, 206:3131-3141.
89. Konopleva M., Andreeff M. Targeting the leukemia microenvironment. Curr Drug Targets 2007, 8:685-701.
90. Manabe A., Coustan-Smith E., Behm F.G., et al. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992, 79:2370-2377.
91. Manabe A., Murti K.G., Coustan-Smith E., et al. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 1994, 83:758-766.
92. Bradstock K., Makrynikola V., Bianchi A., et al. Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts. Blood 1993, 82:3437-3444.
93. Geijtenbeek T.B.H., van Kooyk Y., van Vliet S.J., et al. High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood 1999, 94:754-764.
94. Sipkins D.A., Wei X., Wu J.W., et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumor engraftment. Nature 2005, 435:969-973.
95. Juárez J., Dela Pena A., Baraz R., et al. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Leukemia 2007, 21:1249-1257.
96. Juárez J.G., Thien M., Dela Pena A., et al. CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK. Br J Haematol 2009, 145:491-499.
97. Mowafi F., Cagigi A., Matskova L., et al. Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation. Pediatr Blood Cancer 2008, 50:812-817.
98. Freret M., Gouel F., Buquet C., et al. Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1α (CXCL12). Leuk Res 2011, 35:971-973.
99. MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells. Cell Cycle 2009, 8:2977-2985.
100. De Vasconcellos J.F., Laranjeira A., Zanchin N.I., et al. Increased CCL2 and IL-8 in the bone marrow microenvironment in acute lymphoblastic leukemia. Pediatr Blood Cancer 2011, 56:568-577.
101. Milne C.D., Paige C.J. IL-7: a key regulator of B lymphopoiesis. Sem Immunol 2006, 18:20-30.
102. Parrish Y.K., Baez I., Milford T.A., et al. IL-7 dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol 2009, 182:4255-4266.
103. + severe combined immunodeficiency disease. Curr Opin Immunol 2000, 12:468-473.
104. Johnson S.E., Shah N., Panoskaltsis-Mortari A., et al. Murine and human IL-7 activate STAT5 and induce proliferation of normal human ProB cells. J Immunol 2005, 175:7325-7331.
105. Taguchi T., Takenouchi H., Shiozawa Y., et al. Interleukin 7 contributes to human pro-B cell development in a mouse stromal cell-dependent culture system. Exp Hematol 2007, 35:1398-1407.
106. Brown V.I., Fang J., Alcorn K., et al. Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling. Proc Natl Acad Sci USA 2003, 100:15113-15118.
107. +, Arf-null lymphoblastic leukemia. Genes Dev 2007, 21:2283-2287.
108. Sasson S.C., Smith S., Seddiki N., et al. IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers. Cytokine 2010, 50:58-68.
109. Shochat C., Tal N., Bandapalli O., et al. Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 2011, 208:901-908.
110. Silva A., Laranjeira A.B.A., Martins L.R., et al. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias. Cancer Res 2011, 71:4780-4789.
111. Tesfai Y., Ford J., Carter K.W., et al. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy. Leuk Res 2012, 36:299-306.
112. Iwamoto S., Mihara K., Downing J.R., et al. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest 2007, 117:1049-1057.
113. Raaijmakers M. Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system. Haematologica 2011, 96:1041-1048.
114. Ishikawa F., Yoshioda S., Saito Y., et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone marrow endosteal region. Nat Biotechnol 2007, 25:1315-1321.
115. Colmone A., Amorim M., Pontier A.L., et al. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008, 322:1861-1865.
116. Lane S.W., Wang Y.J., Lo Celso C., et al. Differential niche and Wnt requirements during acute myeloid leukemia progression. Blood 2011, 118:2849-2856.
117. Armstrong S.A., Mabon M.E., Silverman L.B., et al. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood 2004, 103:3544-3546.
118. Ayala F., Dewar R., Kieran M., et al. Contribution of bone microenvrionmental to leukemogenesis and leukemia progression. Leukemia 2009, 23:2233-2241.
119. Bertrand F.E., Eckfeld C.E., Fink J.R., et al. Microenvironmental influences on human B cell-development. Immunol Rev 2000, 175:175-186.
120. Chung E.J., Hwang S.G., Nguyen P.M., et al. Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin. Blood 2002, 100:982-990.
121. Fakler M., Loeder S., Vogler M., et al. Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance. Blood 2009, 113:1710-1722.
122. Norén-Nyström U., Roos G., Bergh A., et al. Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome. Leukemia 2008, 22:504-510.
123. Nygren M.K., Dosen G., Hystad M.E., et al. Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines. Br J Haematol 2006, 136:400-413.
124. Burger J.A., Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 2009, 23:43-52.
125. Román-Gómez J., Cordeu L., Agirre X., et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007, 109:3462-3469.
126. Shalapour S., Eckert C., Seeger K., et al. Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia. J Mol Med 2010, 88:249-265.
127. Verrills N.M., Po'uha S.T., Liu M.L.M., et al. Alterations in γ-actin and tubulin-targeted drug resistance in childhood leukemia. J Natl Cancer Inst 2006, 98:1363-1374.
128. Tabe Y., Jin L., Tsutsumi-Ishii Y., et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007, 67:684-694.
129. Zhao C., Blum J., Chen A., et al. Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12:528-541.
130. Jin L., Tabe Y., Konopleva S., et al. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther 2008, 7:48-58.